CD4 and type 1 diabetes mellitus: Following combination treatment, CD4+CD25+Foxp3+ Tregs significantly expanded in vivo, expressed canonical Tregs markers, enhanced suppressive function in vitro, and spontaneously inhibited T1D in NOD mice.